[go: up one dir, main page]

NO20033368L - New alkyl-phenylimino-imidazolidine derivatives for the treatment of urinary incontinence - Google Patents

New alkyl-phenylimino-imidazolidine derivatives for the treatment of urinary incontinence

Info

Publication number
NO20033368L
NO20033368L NO20033368A NO20033368A NO20033368L NO 20033368 L NO20033368 L NO 20033368L NO 20033368 A NO20033368 A NO 20033368A NO 20033368 A NO20033368 A NO 20033368A NO 20033368 L NO20033368 L NO 20033368L
Authority
NO
Norway
Prior art keywords
phenylimino
treatment
urinary incontinence
imidazolidine derivatives
new alkyl
Prior art date
Application number
NO20033368A
Other languages
Norwegian (no)
Other versions
NO20033368D0 (en
Inventor
Hisato Kitagawa
Pascale Pouzet
Franz Esser
Matthias Hoffmann
Kenji Sakai
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20033368L publication Critical patent/NO20033368L/en
Publication of NO20033368D0 publication Critical patent/NO20033368D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20033368A 2001-02-10 2003-07-28 New alkyl-phenylimino-imidazolidine derivatives for the treatment of urinary incontinence NO20033368D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106214A DE10106214A1 (en) 2001-02-10 2001-02-10 New alkyl-phenylimino-imidazolidine derivatives for the treatment of urinary incontinence
PCT/EP2002/000576 WO2002064570A1 (en) 2001-02-10 2002-01-22 Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence

Publications (2)

Publication Number Publication Date
NO20033368L true NO20033368L (en) 2003-07-28
NO20033368D0 NO20033368D0 (en) 2003-07-28

Family

ID=7673601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033368A NO20033368D0 (en) 2001-02-10 2003-07-28 New alkyl-phenylimino-imidazolidine derivatives for the treatment of urinary incontinence

Country Status (21)

Country Link
EP (1) EP1362038A1 (en)
JP (1) JP2004517963A (en)
KR (1) KR20030076653A (en)
CN (1) CN1491216A (en)
AR (1) AR035226A1 (en)
BG (1) BG108036A (en)
BR (1) BR0206949A (en)
CA (1) CA2437809A1 (en)
CZ (1) CZ20032146A3 (en)
DE (1) DE10106214A1 (en)
EA (1) EA200300835A1 (en)
EC (1) ECSP034700A (en)
EE (1) EE200300379A (en)
HU (1) HUP0303004A3 (en)
IL (1) IL157297A0 (en)
MX (1) MXPA03007127A (en)
NO (1) NO20033368D0 (en)
PL (1) PL362149A1 (en)
SK (1) SK10132003A3 (en)
WO (1) WO2002064570A1 (en)
ZA (1) ZA200305609B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE406363T1 (en) * 2003-05-09 2008-09-15 Hoffmann La Roche METHYLINDOLES AND METHYLPYRROLOPYRIDINES AS ALPHA-1-ADRENERGIC AGONISTS
JP4168086B1 (en) * 2008-04-16 2008-10-22 国立大学法人福井大学 Imidazoline derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3190802A (en) * 1961-10-09 1965-06-22 Boehringer Sohn Ingelheim Shaving composition and method of using same
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
DE19514579A1 (en) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Use of alpha-1-olone agonists for the treatment of urinary incontinence
FR2761061B1 (en) * 1997-03-20 1999-04-23 Synthelabo BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
BR0206949A (en) 2004-02-25
WO2002064570A1 (en) 2002-08-22
SK10132003A3 (en) 2004-02-03
HUP0303004A3 (en) 2004-07-28
PL362149A1 (en) 2004-10-18
ZA200305609B (en) 2004-04-29
CZ20032146A3 (en) 2003-12-17
DE10106214A1 (en) 2002-08-14
HUP0303004A2 (en) 2003-12-29
JP2004517963A (en) 2004-06-17
MXPA03007127A (en) 2003-11-18
EP1362038A1 (en) 2003-11-19
IL157297A0 (en) 2004-02-19
KR20030076653A (en) 2003-09-26
NO20033368D0 (en) 2003-07-28
CN1491216A (en) 2004-04-21
BG108036A (en) 2004-12-30
AR035226A1 (en) 2004-05-05
CA2437809A1 (en) 2002-08-22
EE200300379A (en) 2003-12-15
ECSP034700A (en) 2003-08-29
EA200300835A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
NO20014960D0 (en) New methods of treatment
NO20041833L (en) Heterocyclic compounds for use in the treatment of urinary tract disorders
NO20031442L (en) Morpholine-acetamide derivatives for the treatment of inflammatory diseases
IL229160B (en) Rapamycin derivatives for the treatment of solid tumors
NO20024005L (en) Pteridine compounds for the treatment of psoriasis
NO20014950L (en) New methods of treatment
NO20052894D0 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
EE200300396A (en) Use of epothilone derivatives for the treatment of refractory tumors
EE200300397A (en) Epothilone derivatives for the treatment of refractory tumors
NO20041386L (en) Combinations for the treatment of immuno-inflammatory disorders
IL158050A0 (en) Use of selective cox-2 inhibitors for the treatment of urinary incontinence
PL369062A1 (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
DK1516596T3 (en) Improved system for the treatment of stress urinary incontinence
NO20030978L (en) Treatment of urinary dysfunction
NO20033368D0 (en) New alkyl-phenylimino-imidazolidine derivatives for the treatment of urinary incontinence
NO20012569D0 (en) Use of aryl-substituted cyclobutylamines for the treatment of urinary incontinence
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
NO20031697D0 (en) New M-amino-phenylimino-imidazoline derivatives for the treatment of urinary incontinence
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
NO20033290D0 (en) Pyrrole derivatives for the treatment of cytokine-mediated diseases
NO20033428L (en) Use of 2-amino-1 (4-hydroxy-3-methanesulfonamidophenyl) ethanol for the treatment of urinary incontinence
AU2003283153A8 (en) Pharmaceutical compositions for the treatment of urinary incontinence
SI1413305T1 (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
AU2002317183A1 (en) ARYL (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
NO20014476D0 (en) Treatment of hiatial hernia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application